|
|
 |
Endocrine/Metabolic
|
 |
Antidiabetic
|
 |
Adjunct to Insulin or metformin therapy in patients with type 2 Diabetes Mellitus whose hyperglycemia can't be managed by diet, exercise, and Insulin or metformin alone, adjunct to diet to lower blood glucose in type 2 diabetes.
|
 |
25-100 mg with each meal.
|
 |
Category B
|
 |
Upset stomach, Diarrhea, flatulence, abdominal pain, flatulence, elevated serum transaminase levels.
|
Pregnancy Risk Categories defined:
A: Studies in pregnant women failed to show a risk to the fetus in the first
trimester - with no evidence of risk in the later trimesters.
B: Animals studies indicate no adverse effect to the fetus, but there are no adequate,
clinical studies in pregnant women.
C: Animal studies have shown an adverse effect on the fetus, but there are no adequate,
clinical studies in humans. Despite potential risks, the drug may be useful in pregnant
women.
D: There is evidence of risk to the human fetus, but the potential benefits of use in
pregnant women may be acceptable, despite potential risks.
X: Studies in animals or humans show fetal abnormalities, or adverse reaction reports
indicate evidence of fetal risk. Warning: the risks involved clearly outweigh any
potential benefit from using the drug in pregnant women, regardless of trimester.
NR: Not rated (i.e., no information available at this time as to the potential
risks or benefits).
|
| | |
If you want your friend to read or know about this article, Click here
 |
|
|
